Search Results

ZOVISERT 50

SERTRALINE 50mg. IP

Send Enquiry

MIND

Tablets

Packaging and packing Type

Alu Alu | 10x10

MRP :

₹122

PTR :

₹87.14

PTS :

₹78.43

An antidepressant drug that is indicated in the treatment of neurological diseases such as depression, anxiety, obsessive-compulsive disorder, and pos... Read More

Composition

SERTRALINE 50mg. IP

Send Enquiry

India’s Largest Pharma Franchise

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

Description

An antidepressant drug that is indicated in the treatment of neurological diseases such as depression, anxiety, obsessive-compulsive disorder, and posttraumatic stress disorder. A potent and selective inhibitor of serotonin reuptake exerts both antidepressant and antianxiety effects. (G MacQueen, 2001) A promising therapeutic and prophylactic alternative in the pharmacologic management of depression. (Shelton, 1994) Reduces anxiety symptoms such as nervousness, irritability, and restlessness in depressed individuals. (Mahase, 2019) Offers advantages over selective serotonin reuptake inhibitors namely, paroxetine, fluoxetine, and fluvoxamine in elderly patients with major depressive disorder. (Richard B R Muijsers G. L., 2002) The first‐line agent for the treatment of several psychiatric disorders. (Glenda MacQueen, 2001) A well-tolerated treatment for generalized anxiety disorder in both men and women. (Meir Steiner, 2005) An efficacious candidate for the treatment of depression and obsessive-compulsive disorder. (Guthrie, 1991) Produces greater improvements in the quality of a patient’s life and is better tolerated than amitriptyline therapy in patients with major depression. (R B Lydiard, 1997) Shows significantly greater tolerability and compliance during long-term treatment than imipramine in patients with panic disorder and major depressive disorder. (Ulla Lepola, 2003) Demonstrates a significantly greater reduction in depression severity compared to nortriptyline. (S I Finkel, 1999)

Side Effects

Nausea, Diarrhea, Loss of appetite, Insomnia, Tiredness, Constipation, Headache

Indication

Depression , Anxiety disorder , Social anxiety disorder , Panic attacks , Obsessive-compulsive disorder , Post-traumatic stress disorder

Important Notice

Temp data

Storage Condition

Product details for storage condition Product details for storage condition Product details for storage condition Product details for storage condition

Similar Products

No products found.

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Franchise Enquiry

Request a callback to get more information about becoming a PCD Franchise Owner***

    Send Enquiry

    Request a callback to get more information about becoming a PCD Franchise Owner